Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial collaboration with MSD (Merck Co., Inc., Rahway
Co-founder and CEO Mike Romanos steps down after six years to take up role of Associate Dean of Enterprise in the Faculty of Medicine at Imperial College Tim Sharpington, Microbiotica COO
Microbiotica's Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.